Quartan malarial nephrotic syndrome. Collaborative clinicopathological study in Nigerian children.
D000962:Antimalarials / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001485:Basement Membrane / Q000473:pathology; D001706:Biopsy; D002196:Capillaries / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007678:Kidney Glomerulus / Q000473:pathology; D008288:Malaria / Q000150:complications* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D008297:Male; D009404:Nephrotic Syndrome / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D009549:Nigeria; D011239:Prednisolone / Q000627:therapeutic use
D000962:Antimalarials; D007136:Immunoglobulins; D003520:Cyclophosphamide; D011239:Prednisolone; D001379:Azathioprine